Epidemiology of invasive candidiasis
The DOI matches its Crossref record; 211 of the 212 references it cites were found in a registry or an index.
Abstract
Purpose of review This review covers candidaemia in numbers, susceptibility issues, host groups, risk factors and outcome. Recent findings The incidence of candidaemia has increased over the last decades. Candida glabrata is particularly common in the northern hemisphere and with increasing age whilst the opposite is true for C. parapsilosis, C. glabrata, C. krusei and a number of emerging species are not fully susceptible to azoles. C. parapsilosis and C. guilliermondii are not fully susceptible to echinocandins. Increasing rates of C. parapsilosis have been observed at centres with a high use of echinocandins, and outcome for this species is not superior comparing echinocandins with fluconazole. Acquired azole resistance has recently been described in as many as a third of 19% resistant isolates and echinocandin resistance has emerged and been detected as early as day 12 of echinocandin therapy. ICU stay and abdominal surgery are among the most important risk factors. Outcome is dependent on species involved, timing, dosing and choice of therapy and management of the primary focus of infection. However, host factors are dominating predictors of mortality in recent studies of ICU candidiasis. Summary The changing epidemiology highlights the need for close monitoring of local incidence, species distribution and susceptibility in order to optimize therapy and outcome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Comparisons of the incidence across countries is difficult as recent local epidemiological data was only available for 20 of the countries and the others used an incidence of 5 per 100,000 cases for their estimations [46].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [46]
In the citing paper
“Specifically, C. glabrata has become an important pathogen in North America, Europe (with the exception of Spain), and Australia, whereas C. parapsilosis is the dominant non-albicans species in South America, Japan, and Spain [8,9,10].”
From Treatment of Invasive Candidiasis: A Narrative Review (2018) · cites this paper as [9]
Citations
Cites
Guidelines for the Prevention of Intravascular Catheter-related Infections
O'Grady, N. P., Alexander, M., Burns, L. A., Dellinger, E. P., Garland, J., Heard, S. O., Lipsett, P. A., Masur, H., Mermel, L. A., Pearson, M. L., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir257 · Cited by 4,699
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Vincent, J.-L. (2009) · JAMA · doi:10.1001/jama.2009.1754 · Cited by 3,618
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
Guidelines for Treatment of Candidiasis
Pappas, P. G., Rex, J. H., Sobel, J. D., Filler, S. G., Dismukes, W. E., Walsh, T. J., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/380796 · Cited by 1,440
Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353
Morrell, M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3640-3645.2005 · Cited by 1,286
Garey, K. W., Rege, M., Pai, M. P., Mingo, D. E., Suda, K. J., Turpin, R. S., & Bearden, D. T. (2006) · Clinical Infectious Diseases · doi:10.1086/504810 · Cited by 1,171
Rex, J. H., Bennett, J. E., Sugar, A. M., Pappas, P. G., van der Horst, C. M., Edwards, J. E., Washburn, R. G., Scheld, W. M., Karchmer, A. W., Dine, A. P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411173312001 · Cited by 1,039
Wingard, J. R., Merz, W. G., Rinaldi, M. G., Johnson, T. R., Karp, J. E., & Saral, R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110313251803 · Cited by 937
Anidulafungin versus Fluconazole for Invasive Candidiasis
Reboli, A. C., Rotstein, C., Pappas, P. G., Chapman, S. W., Kett, D. H., Kumar, D., Betts, R., Wible, M., Goldstein, B. P., Schranz, J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066906 · Cited by 894
Rex, J. H., Pfaller, M. A., Galgiani, J. N., Bartlett, M. S., Espinel-Ingroff, A., Ghannoum, M. A., Lancaster, M., Odds, F. C., Rinaldi, M. G., Walsh, T. J., et al. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.2.235 · Cited by 855
Pappas, P. G., Rex, J. H., Lee, J., Hamill, R. J., Larsen, R. A., Powderly, W., Kauffman, C. A., Hyslop, N., Mangino, J. E., Chapman, S., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/376906 · Cited by 845
Hospital-Acquired Candidemia: The Attributable Mortality and Excess Length of Stay
Wey, S. B. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380120094019 · Cited by 831
Vermes, A. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.2.171 · Cited by 803
Candida Colonization and Subsequent Infections in Critically III Surgical Patients
Pittet, D., Monod, M., Suter, P. M., Frenk, E., & Auckenthaler, R. (1994) · Annals of Surgery · doi:10.1097/00000658-199412000-00008 · Cited by 798
Invasive Aspergillosis Disease Spectrum, Treatment Practices, and Outcomes
Patterson, T. F., Kirkpatrick, W. R., White, M., Hiemenz, J. W., WINGARD, J. R., DUPONT, B., RINALDI, M. G., STEVENS, D. A., & Graybill, J. R. (2000) · Medicine · doi:10.1097/00005792-200007000-00006 · Cited by 791
Zaoutis, T. E., Argon, J., Chu, J., Berlin, J. A., Walsh, T. J., & Feudtner, C. (2005) · Clinical Infectious Diseases · doi:10.1086/496922 · Cited by 784
Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Ellis, D., Tullio, V., Rodloff, A., Fu, W., & Ling, T. A. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02117-09 · Cited by 718
Pfaller, M. A., & Diekema, D. J. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.10.4419-4431.2004 · Cited by 694
Trick, W. E., Fridkin, S. K., Edwards, J. R., Hajjeh, R. A., Gaynes, R. P., & Hospitals, T. N. N. I. S. S. (2002) · Clinical Infectious Diseases · doi:10.1086/342300 · Cited by 660
Hajjeh, R. A., Sofair, A. N., Harrison, L. H., Lyon, G. M., Arthington-Skaggs, B. A., Mirza, S. A., Phelan, M., Morgan, J., Lee-Yang, W., Ciblak, M. A., et al. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.4.1519-1527.2004 · Cited by 649
Infections due to emerging and uncommon medically important fungal pathogens
Walsh, T. J., Groll, A., Hiemenz, J., Fleming, R., Roilides, E., & Anaissie, E. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1470-9465.2004.00839.x · Cited by 601
Viscoli, C., Girmenia, C., Marinus, A., Collette, L., Martino, P., Vandercam, B., Doyen, C., Lebeau, B., Spence, D., Krcmery, V., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/514731 · Cited by 601
Risk factors for candidemia in Neonatal Intensive Care Unit patients
SAIMAN, L., LUDINGTON, E., PFALLER, M., RANGEL-FRAUSTO, S., WIBLIN, T. R., DAWSON, J., BLUMBERG, H. M., PATTERSON, J. E., RINALDI, M., EDWARDS, J. E., et al. (2000) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200004000-00011 · Cited by 587
Almirante, B., Rodríguez, D., Park, B. J., Cuenca-Estrella, M., Planes, A. M., Almela, M., Mensa, J., Sanchez, F., Ayats, J., Gimenez, M., et al. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.4.1829-1835.2005 · Cited by 566
Importance of Candida Species Other than C. albicans as Pathogens in Oncology Patients
Wingard, J. R. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.1.115 · Cited by 542
Leroy, O., Gangneux, J.-P., Montravers, P., Mira, J.-P., Gouin, F., Sollet, J.-P., Carlet, J., Reynes, J., Rosenheim, M., Regnier, B., et al. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819efac0 · Cited by 535
Colombo, A. L., Nucci, M., Park, B. J., Nouér, S. A., Arthington-Skaggs, B., da Matta, D. A., Warnock, D., & Morgan, J. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00773-06 · Cited by 526
Tortorano, A. M., Peman, J., Bernhardt, H., Klingspor, L., Kibbler, C. C., Faure, O., Biraghi, E., Canton, E., Zimmermann, K., Seaton, S., et al. (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1103-y · Cited by 509
Nosocomial Candidiasis: Emerging Species, Reservoirs, and Modes of Transmission
Pfaller, M. A. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.supplement_2.s89 · Cited by 502
Nosocomial Candidemia: Risk Factors and Attributable Mortality
Wenzel, R. P. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.6.1531 · Cited by 502
Antifungal Susceptibility Survey of 2,000 Bloodstream Candida Isolates in the United States
Ostrosky-Zeichner, L., Rex, J. H., Pappas, P. G., Hamill, R. J., Larsen, R. A., Horowitz, H. W., Powderly, W. G., Hyslop, N., Kauffman, C. A., Cleary, J., et al. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3149-3154.2003 · Cited by 498
Rex, J. H., Pappas, P. G., Karchmer, A. W., Sobel, J., Edwards, J. E., Hadley, S., Brass, C., Vazquez, J. A., Chapman, S. W., Horowitz, H. W., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/374850 · Cited by 495
Epidemiology of Candidemia in Swiss Tertiary Care Hospitals: Secular Trends, 1991–2000
Marchetti, O., Bille, J., Fluckiger, U., Eggimann, P., Ruef, C., Garbino, J., Calandra, T., Glauser, M., Tauber, M. G., Pittet, D., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/380637 · Cited by 478
Kao, A. S., Brandt, M. E., Pruitt, W. R., Conn, L. A., Perkins, B. A., Stephens, D. S., Baughman, W. S., Reingold, A. L., Rothrock, G. A., Pfaller, M. A., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/313450 · Cited by 457
Invasive Fungal Pathogens: Current Epidemiological Trends
Pfaller, M. A., Pappas, P. G., & Wingard, J. R. (2006) · Clinical Infectious Diseases · doi:10.1086/504490 · Cited by 448
Antifungal Susceptibility Testing: Practical Aspects and Current Challenges
Rex, J. H., Pfaller, M. A., Walsh, T. J., Chaturvedi, V., Espinel-Ingroff, A., Ghannoum, M. A., Gosey, L. L., Odds, F. C., Rinaldi, M. G., Sheehan, D. J., et al. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.643-658.2001 · Cited by 444
Nucci, M., & Marr, K. A. (2005) · Clinical Infectious Diseases · doi:10.1086/432060 · Cited by 435
Park, S., Kelly, R., Kahn, J. N., Robles, J., Hsu, M.-J., Register, E., Li, W., Vyas, V., Fan, H., Abruzzo, G., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3264-3273.2005 · Cited by 434
Pfaller, M. A., & Diekema, D. J. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1470-9465.2004.t01-1-00844.x · Cited by 423
Weems, J. J. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.3.756 · Cited by 399
Rees, J. R., Pinner, R. W., Hajjeh, R. A., Brandt, M. E., & Reingold, A. L. (1998) · Clinical Infectious Diseases · doi:10.1093/clinids/27.5.1138 · Cited by 397
Diekema, D. J., Messer, S. A., Brueggemann, A. B., Coffman, S. L., Doern, G. V., Herwaldt, L. A., & Pfaller, M. A. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.4.1298-1302.2002 · Cited by 385
León, C., Ruiz-Santana, S., Saavedra, P., Galván, B., Blanco, A., Castro, C., Balasini, C., Utande-Vázquez, A., González de Molina, F. J., Blasco-Navalproto, M. A., et al. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819daa14 · Cited by 375
The direct cost and incidence of systemic fungal infections
Wilson, L. S., Reyes, C. M., Stolpman, M., Speckman, J., Allen, K., & Beney, J. (2002) · Value in Health · doi:10.1046/j.1524-4733.2002.51108.x · Cited by 374
Has antifungal susceptibility testing come of age
Rex, J. H., & Pfaller, M. A. (2002) · Clinical Infectious Diseases · doi:10.1086/342384 · Cited by 361
The Impact of Hospital-Acquired Bloodstream Infections
Wenzel, R. P., & Edmond, M. B. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0702.010203 · Cited by 359
Candidaemia in Europe: epidemiology and resistance
TORTORANO, A., KIBBLER, C., PEMAN, J., BERNHARDT, H., KLINGSPOR, L., & GRILLOT, R. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.01.002 · Cited by 352
Wingard, J. R., Merz, W. G., Rinaldi, M. G., Miller, C. B., Karp, J. E., & Saral, R. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.9.1847 · Cited by 340
Shin, J. H., Kee, S. J., Shin, M. G., Kim, S. H., Shin, D. H., Lee, S. K., Suh, S. P., & Ryang, D. W. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.4.1244-1248.2002 · Cited by 334
Sanguinetti, M., Posteraro, B., Fiori, B., Ranno, S., Torelli, R., & Fadda, G. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.668-679.2005 · Cited by 319
Pelz, R. K., Hendrix, C. W., Swoboda, S. M., Diener-West, M., Merz, W. G., Hammond, J., & Lipsett, P. A. (2001) · Annals of Surgery · doi:10.1097/00000658-200104000-00010 · Cited by 316
The Impact of Candidemia on Length of Hospital Stay, Outcome, and Overall Cost of Illness
Rentz, A. M., Halpern, M. T., & Bowden, R. (1998) · Clinical Infectious Diseases · doi:10.1086/514955 · Cited by 310
Pfaller, M. A., Diekema, D. J., & Sheehan, D. J. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.2.435-447.2006 · Cited by 295
Vincent, J. L., Anaissie, E., Bruining, H., Demajo, W., El-Ebiary, M., Haber, J., Hiramatsu, Y., Nitenberg, G., Nyström, P. O., Pittet, D., et al. (1998) · Intensive Care Medicine · doi:10.1007/s001340050552 · Cited by 277
Sipsas, N. V., Lewis, R. E., Tarrand, J., Hachem, R., Rolston, K. V., Raad, I. I., & Kontoyiannis, D. P. (2009) · Cancer · doi:10.1002/cncr.24507 · Cited by 269
Pfaller, M. A., & Diekema, D. J. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.10.3551-3557.2002 · Cited by 269
Winston, D. J., Pakrasi, A., & Busuttil, R. W. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-10-199911160-00003 · Cited by 261
Pfaller, M. A., Diekema, D. J., Rex, J. H., Espinel-Ingroff, A., Johnson, E. M., Andes, D., Chaturvedi, V., Ghannoum, M. A., Odds, F. C., Rinaldi, M. G., et al. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.3.819-826.2006 · Cited by 258
Current Treatment Strategies for Disseminated Candidiasis
Spellberg, B. J., Filler, S. G., & Edwards, J. E. (2006) · Clinical Infectious Diseases · doi:10.1086/499057 · Cited by 256
Garcia-Effron, G., Park, S., & Perlin, D. S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01162-08 · Cited by 256
Invasive candidiasis in the intensive care unit
Ostrosky-Zeichner, L., & Pappas, P. G. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000201897.78123.44 · Cited by 247
Pfaller, M. A., Messer, S. A., Hollis, R. J., Jones, R. N., & Diekema, D. J. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1723-1727.2002 · Cited by 232
Parkins, M. D., Sabuda, D. M., Elsayed, S., & Laupland, K. B. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm212 · Cited by 229
In Vivo Comparison of the Pharmacodynamic Targets for Echinocandin Drugs against Candida Species
Andes, D., Diekema, D. J., Pfaller, M. A., Bohrmuller, J., Marchillo, K., & Lepak, A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01584-09 · Cited by 226
Nguyen, M. H., Clancy, C. J., Yu, V. L., Yu, Y. C., Morris, A. J., Snydman, D. R., Sutton, D. A., & Rinaldi, M. G. (1998) · The Journal of Infectious Diseases · doi:10.1086/514193 · Cited by 219
Nolte, F. S., Parkinson, T., Falconer, D. J., Dix, S., Williams, J., Gilmore, C., Geller, R., & Wingard, J. R. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.1.196 · Cited by 219
Piarroux, R., Grenouillet, F., Balvay, P., Tran, V., Blasco, G., Millon, L., & Boillot, A. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000147726.62304.7f · Cited by 216
The Value of Fungal Surveillance Cultures as Predictors of Systemic Fungal Infections
Sandford, G. R., Merz, W. G., Wingard, J. R., Charache, P., & Saral, R. (1980) · Journal of Infectious Diseases · doi:10.1093/infdis/142.4.503 · Cited by 215
Wiederhold, N. P., Kontoyiannis, D. P., Chi, J., Prince, R. A., Tam, V. H., & Lewis, R. E. (2004) · The Journal of Infectious Diseases · doi:10.1086/424465 · Cited by 207
Wanger, A., Mills, K., Nelson, P. W., & Rex, J. H. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2520 · Cited by 202
Detection of amphotericin B-resistant Candida isolates in a broth-based system
Rex, J. H., Cooper, C. R., Merz, W. G., Galgiani, J. N., & Anaissie, E. J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.4.906 · Cited by 198
Breakthrough invasive candidiasis in patients on micafungin.
Pfeiffer, C. D., Garcia-Effron, G., Zaas, A. K., Perfect, J. R., Perlin, D. S., & Alexander, B. D. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02390-09 · Cited by 196
In Vitro Susceptibilities of Candida spp. to Caspofungin: Four Years of Global Surveillance
Pfaller, M. A., Boyken, L., Hollis, R. J., Messer, S. A., Tendolkar, S., & Diekema, D. J. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.3.760-763.2006 · Cited by 193
Ostrosky-Zeichner, L., Kontoyiannis, D., Raffalli, J., Mullane, K. M., Vazquez, J., Anaissie, E. J., Lipton, J., Jacobs, P., Rensburg, J. H. J., Rex, J. H., et al. (2005) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-005-0024-8 · Cited by 189
High frequency of yeast carriage on hands of hospital personnel
Strausbaugh, L. J., Sewell, D. L., Ward, T. T., Pfaller, M. A., Heitzman, T., & Tjoelker, R. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.9.2299-2300.1994 · Cited by 188
Increasing Incidence of Candidemia: Results from a 20-Year Nationwide Study in Iceland
Ásmundsdóttir, L. R., Erlendsdóttir, H., & Gottfredsson, M. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.9.3489-3492.2002 · Cited by 188
Management and outcome of bloodstream infections due to Candida species in England and Wales
Kibbler, C. C., Seaton, S., Barnes, R. A., Gransden, W. R., Holliman, R. E., Johnson, E. M., Perry, J. D., Sullivan, D. J., & Wilson, J. A. (2003) · Journal of Hospital Infection · doi:10.1016/s0195-6701(03)00085-9 · Cited by 187
Pfaller, M. A., Messer, S. A., Boyken, L., Tendolkar, S., Hollis, R. J., & Diekema, D. J. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.7.3142-3146.2004 · Cited by 182
Towards a targeted, risk‐based, antifungal strategy in neutropenic patients
Prentice, H. G., Kibbler, C. C., & Prentice, A. G. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02014.x · Cited by 181
Paphitou, N. I., Ostrosky-Zeichner, L., & Rex, J. H. (2005) · Medical Mycology · doi:10.1080/13693780410001731619 · Cited by 179
Sarvikivi, E., Lyytikäinen, O., Soll, D. R., Pujol, C., Pfaller, M. A., Richardson, M., Koukila-Kähkölä, P., Luukkainen, P., & Saxén, H. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.6.2729-2735.2005 · Cited by 178
Arendrup, M. C., Fuursted, K., Gahrn-Hansen, B., Jensen, I. M., Knudsen, J. D., Lundgren, B., Schønheyder, H. C., & Tvede, M. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.9.4434-4440.2005 · Cited by 178
Self-citationOne year prospective survey of Candida bloodstream infections in Scotland
Odds, F. C., Hanson, M. F., Davidson, A. D., Jacobsen, M. D., Wright, P., Whyte, J. A., Gow, N. A. R., & Jones, B. L. (2007) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47239-0 · Cited by 176
Clancy, C. J., Yu, V. L., Morris, A. J., Snydman, D. R., & Nguyen, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3171-3177.2005 · Cited by 176
Active Surveillance of Candidemia, Australia
Chen, S., Slavin, M., Nguyen, Q., Marriott, D., Playford, E. G., Ellis, D., Sorrell, T., & Study, T. A. C. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1210.060389 · Cited by 174
Odds, F. C., Motyl, M., Andrade, R., Bille, J., Cantón, E., Cuenca-Estrella, M., Davidson, A., Durussel, C., Ellis, D., Foraker, E., et al. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.8.3475-3482.2004 · Cited by 173
Candidemia in Norway (1991 to 2003): Results from a Nationwide Study
Sandven, P., Bevanger, L., Digranes, A., Haukland, H. H., Mannsåker, T., Gaustad, P., & the Norwegian Yeast Study Group (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00029-06 · Cited by 173
Vertical and Horizontal Transmission of Unique Candida Species to Premature Newborns
Waggoner-Fountain, L. A., Whit Walker, M., Hollis, R. J., Pfaller, M. A., Ferguson, J. E., Wenzel, R. P., & Donowitz, L. G. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.5.803 · Cited by 172
In Vivo Pathogenicity of Eight Medically Relevant Candida Species in an Animal Model
Arendrup, M., Horn, T., & Frimodt-Møller, N. (2002) · Infection · doi:10.1007/s15010-002-2131-0 · Cited by 168
Self-citationTassel, D. (1968) · JAMA · doi:10.1001/jama.206.4.830 · Cited by 164
Association of fluconazole pharmacodynamics with mortality in patients with candidemia
Baddley, J. W., Patel, M., Bhavnani, S. M., Moser, S. A., & Andes, D. R. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00116-08 · Cited by 162
Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death
Slavin, M. A., Sorrell, T. C., Marriott, D., Thursky, K. A., Nguyen, Q., Ellis, D. H., Morrissey, C. O., Chen, S. C. A., & on behalf of the Australian Candidemia Study, A. S. F. I. D. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq053 · Cited by 162
Pfaller, M. A., Boyken, L., Hollis, R. J., Messer, S. A., Tendolkar, S., & Diekema, D. J. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.11.5425-5427.2005 · Cited by 161
Review of Newer Antifungal and Immunomodulatory Strategies for Invasive Aspergillosis
Steinbach, W. J., & Stevens, D. A. (2003) · Clinical Infectious Diseases · doi:10.1086/376523 · Cited by 161
Pai, M. P., Turpin, R. S., & Garey, K. W. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00474-06 · Cited by 159
Wenzel, R. P., & Gennings, C. (2005) · Clinical Infectious Diseases · doi:10.1086/430923 · Cited by 159
Playford, E. G., Webster, A. C., Sorrell, T. C., & Craig, J. C. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki491 · Cited by 159
YU, M., & TOMASA, G. (1993) · Critical Care Medicine · doi:10.1097/00003246-199311000-00010 · Cited by 158
Arendrup, M. C., Garcia-Effron, G., Lass-Flörl, C., Lopez, A. G., Rodriguez-Tudela, J.-L., Cuenca-Estrella, M., & Perlin, D. S. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01256-09 · Cited by 158
Self-citationRoilides, E., Farmaki, E., Evdoridou, J., Dotis, J., Hatziioannidis, E., Tsivitanidou, M., Bibashi, E., Filioti, I., Sofianou, D., Gil‐Lamaignere, C., et al. (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1210-9 · Cited by 157
Prophylactic antifungal therapy in the intensive care unit
Weinstein, R. A., Rex, J. H., & Sobel, J. D. (2001) · Clinical Infectious Diseases · doi:10.1086/319763 · Cited by 155
White, M. H. (1997) · Clinical Infectious Diseases · doi:10.1086/513661 · Cited by 151
Lin, M. Y., Carmeli, Y., Zumsteg, J., Flores, E. L., Tolentino, J., Sreeramoju, P., & Weber, S. G. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4555-4560.2005 · Cited by 150
Economic Impact of Candida Colonization and Candida Infection in the Critically Ill Patient
Jord�, R., Nolla‐Salas, J., Le�n-Regidor, M. A., lvarez-Lerma, F., Olaechea, P., Palomar, M., & Le�n-Gil, C. (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1104-x · Cited by 145
The echinocandin antifungals: an overview of the pharmacology, spectrum and clinical efficacy
Wiederhold, N. P., & Lewis, R. E. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.8.1313 · Cited by 144
Clinical Significance of Azole Antifungal Drug Cross-Resistance in Candida glabrata
Panackal, A. A., Gribskov, J. L., Staab, J. F., Kirby, K. A., Rinaldi, M., & Marr, K. A. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.5.1740-1743.2006 · Cited by 144
Increasing incidence of Candida parapsilosis candidemia with caspofungin usage.
Forrest, G. N., Weekes, E., & Johnson, J. K. (2008) · Journal of Infection · doi:10.1016/j.jinf.2007.10.014 · Cited by 144
Mechanisms of Azole Resistance in a Clinical Isolate of Candida tropicalis
Vandeputte, P., Larcher, G., Bergès, T., Renier, G., Chabasse, D., & Bouchara, J.-P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4608-4615.2005 · Cited by 141
Arendrup, M. C., Fuursted, K., Gahrn-Hansen, B., Schønheyder, H. C., Knudsen, J. D., Jensen, I., Bruun, B., Christensen, J. J., & Johansen, H. K. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.01954.x · Cited by 134
Self-citationVoriconazole Salvage Treatment of Invasive Candidiasis
Ostrosky-Zeichner, L. L., Lashof, A. M. L. O., Kullberg, B. J., & Rex, J. H. (2003) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-003-1014-3 · Cited by 134
St-Germain, G., Laverdière, M., Pelletier, R., Bourgault, A.-M., Libman, M., Lemieux, C., & Noël, G. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.3.949-953.2001 · Cited by 134
Godoy, P., Tiraboschi, I. N., Severo, L. C., Bustamante, B., Calvo, B., de Almeida, L. P., da Matta, D. A., & Colombo, A. L. (2003) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762003000300020 · Cited by 133
Pfaller, M. A., Messer, S. A., Boyken, L., Huynh, H., Hollis, R. J., & Diekema, D. J. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3518-3521.2002 · Cited by 132
Invasive Candida species infections: a 5 year population-based assessment
Laupland, K. B., Gregson, D. B., Church, D. L., Ross, T., & Elsayed, S. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki258 · Cited by 130
Garcia-Effron, G., Kontoyiannis, D. P., Lewis, R. E., & Perlin, D. S. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00802-08 · Cited by 129
Effect of antifungal therapy timing on mortality in cancer patients with candidemia
Taur, Y., Cohen, N., Dubnow, S., Paskovaty, A., & Seo, S. K. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00945-09 · Cited by 127
Arendrup, M. C., Garcia-Effron, G., Buzina, W., Mortensen, K. L., Reiter, N., Lundin, C., Jensen, H. E., Lass-Flörl, C., Perlin, D. S., & Bruun, B. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01292-08 · Cited by 123
Self-citationCandidemia in Finland, 1995–1999
Poikonen, E., Lyytikäinen, O., Anttila, V.-J., & Ruutu, P. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0908.030069 · Cited by 121
Pathologic Features in the Human Alimentary Tract Associated with Invasiveness of Candida Tropicalis
Walsh, T. J., & Merz, W. G. (1986) · American Journal of Clinical Pathology · doi:10.1093/ajcp/85.4.498 · Cited by 116
Neonatal Candida parapsilosis outbreak with a high case fatality rate
SAXEN, H., VIRTANEN, M., CARLSON, P., HOPPU, K., POHJAVUORI, M., VAARA, M., VUOPIO-VARKILA, J., & PELTOLA, H. (1995) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199509000-00009 · Cited by 113
Park, B. J., Arthington-Skaggs, B. A., Hajjeh, R. A., Iqbal, N., Ciblak, M. A., Lee-Yang, W., Hairston, M. D., Phelan, M., Plikaytis, B. D., Sofair, A. N., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1287-1292.2006 · Cited by 113
Immunotherapy for Fungal Infections
Segal, B. H., Kwon-Chung, J., Walsh, T. J., Klein, B. S., Battiwalla, M., Almyroudis, N. G., Holland, S. M., & Romani, L. (2006) · Clinical Infectious Diseases · doi:10.1086/499811 · Cited by 109
Weinberger, M., Leibovici, L., Perez, S., Samra, Z., Ostfeld, I., Levi, I., Bash, E., Turner, D., Goldschmied‐Reouven, A., Regev‐Yochay, G., et al. (2005) · Journal of Hospital Infection · doi:10.1016/j.jhin.2005.02.009 · Cited by 109
Chen, S. C. A., Marriott, D. J. E., Playford, E. G., Nguyen, Q. A., Ellis, D., Meyer, W., Sorrell, T. C., & Slavin, M. A. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02821.x · Cited by 107
Stiller, R. L., Bennett, J. E., Scholer, H. J., Wall, M., Polak, A., & Stevens, D. A. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.22.3.482 · Cited by 102
Stiller, R. L., Bennett, J. E., Scholer, H. J., Wall, M., Polak, A., & Stevens, D. A. (1983) · Journal of Infectious Diseases · doi:10.1093/infdis/147.6.1070 · Cited by 100
Evaluation of etest for determining in vitro susceptibility of yeast isolates to amphotericin B
Pfaller, M. A., Messer, S. A., & Bolmström, A. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(98)00120-5 · Cited by 99
Sheng, W., Wang, J., Lu, D. C. T., Chie, W., Chen, Y., & Chang, S. (2005) · Journal of Hospital Infection · doi:10.1016/j.jhin.2004.06.003 · Cited by 99
Candida lusitaniae fungemia in cancer patients: risk factors for amphotericin B failure and outcome
Atkinson, B. J., Lewis, R. E., & Kontoyiannis, D. P. (2008) · Medical Mycology · doi:10.1080/13693780801968571 · Cited by 98
MacCallum, D. M., Coste, A., Ischer, F., Jacobsen, M. D., Odds, F. C., & Sanglard, D. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01645-09 · Cited by 98
Manzoni, P., Leonessa, M., Galletto, P., Latino, M. A., Arisio, R., Maule, M., Agriesti, G., Gastaldo, L., Gallo, E., Mostert, M., et al. (2008) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318170bb0c · Cited by 93
Determinants of mortality in non-neutropenic ICU patients with candidaemia.
Marriott, D. J., Playford, E. G., Chen, S., Slavin, M., Nguyen, Q., Ellis, D., Sorrell, T. C., & Study, T. A. C. (2009) · Critical Care · doi:10.1186/cc7964 · Cited by 93
Pujol, C., Pfaller, M., & Soll, D. R. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.8.2729-2740.2002 · Cited by 93
Incidence of candidaemia and relationship with fluconazole use in an intensive care unit
Bassetti, M., Ansaldi, F., Nicolini, L., Malfatto, E., Molinari, M. P., Mussap, M., Rebesco, B., Bobbio Pallavicini, F., Icardi, G., & Viscoli, C. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp251 · Cited by 92
Vardakas, K. Z., Samonis, G., Michalopoulos, A., Soteriades, E. S., & Falagas, M. E. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000208357.05675.c3 · Cited by 91
Yoon, S. A., Vazquez, J. A., Steffan, P. E., Sobel, J. D., & Akins, R. A. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.4.836 · Cited by 90
Pfaller, M. A., Messer, S. A., Boyken, L., Rice, C., Tendolkar, S., Hollis, R. J., & Diekema, D. J. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.7.3117-3119.2004 · Cited by 90
Pfaller, M. A., Boyken, L., Messer, S. A., Tendolkar, S., Hollis, R. J., & Diekema, D. J. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.10.5208-5213.2005 · Cited by 89
Pfaller, M. A., Boyken, L., Hollis, R. J., Messer, S. A., Tendolkar, S., & Diekema, D. J. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00872-06 · Cited by 88
Excess mortality, length of stay and cost attributable to candidaemia
Hassan, I., Powell, G., Sidhu, M., Hart, W. M., & Denning, D. W. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.08.020 · Cited by 88
Improved Detection of Amphotericin B-Resistant Isolates of Candida lusitaniae by Etest
Peyron, F., Favel, A., Michel-Nguyen, A., Gilly, M., Regli, P., & Bolmström, A. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.1.339-342.2001 · Cited by 87
New approaches to the risk of Candida in the intensive care unit
Ostrosky-Zeichner, L. (2003) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200312000-00004 · Cited by 86
Pfaller, M. A., Messer, S. A., & Hollis, R. J. (1994) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/0732-8893(94)90106-6 · Cited by 86
Pfaller, M. A., Messer, S. A., Boyken, L., Tendolkar, S., Hollis, R. J., & Diekema, D. J. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.5.2176-2179.2003 · Cited by 86
Redding, S. W., Kirkpatrick, W. R., Saville, S., Coco, B. J., White, W., Fothergill, A., Rinaldi, M., Eng, T., Patterson, T. F., & Lopez-Ribot, J. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.2.619-622.2003 · Cited by 85
Pfaller, M. A., Boyken, L., Hollis, R. J., Messer, S. A., Tendolkar, S., & Diekema, D. J. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.8.3807-3810.2005 · Cited by 82
Risk Factors for Fluconazole-Resistant Candida glabrata Bloodstream Infections
Lee, I., Fishman, N. O., Zaoutis, T. E., Morales, K. H., Weiner, M. G., Synnestvedt, M., Nachamkin, I., & Lautenbach, E. (2009) · Archives of Internal Medicine · doi:10.1001/archinte.169.4.379 · Cited by 81
Holley, A., Dulhunty, J. M., Blot, S. I., Lipman, J., Lobo, S. M., Dancer, C., Rello, J., & Dimopoulos, G. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.10.035 · Cited by 81
Flucytosine Resistance Is Restricted to a Single Genetic Clade of Candida albicans
Pujol, C., Pfaller, M. A., & Soll, D. R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.262-266.2004 · Cited by 80
Has the Epidemiology of Nosocomial Candidemia Changed?
Puzniak, L., Teutsch, S., Powderly, W., & Polish, L. (2004) · Infection Control & Hospital Epidemiology · doi:10.1086/502452 · Cited by 80
Anidulafungin: A new echinocandin with a novel profile
Vazquez, J. A. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.06.010 · Cited by 78
To, W. K., Fothergill, A. W., & Rinaldi, M. G. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.10.2660-2664.1995 · Cited by 78
Predictive value of surveillance cultures for systemic infection due toCandida species
Pfaller, M. A., Cabezudo, I., Koontz, F. P., Bale, M. J., & Gingrich, R. (1987) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02013057 · Cited by 77
Sharpe, M. D., Ghent, C., Grant, D., Horbay, G. L. A., McDougal, J., & David Colby, W. (2003) · Transplantation · doi:10.1097/01.tp.0000085653.11565.52 · Cited by 73
Invasive Candidiasis: Turning Risk into a Practical Prevention Policy?
Sobel, J. D., & Rex, J. H. (2001) · Clinical Infectious Diseases · doi:10.1086/321812 · Cited by 73
Sendid, B., Cotteau, A., François, N., D'Haveloose, A., Standaert, A., Camus, D., & Poulain, D. (2006) · BMC Infectious Diseases · doi:10.1186/1471-2334-6-80 · Cited by 72
Redding, S. W., Kirkpatrick, W. R., Coco, B. J., Sadkowski, L., Fothergill, A. W., Rinaldi, M. G., Eng, T. Y., & Patterson, T. F. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.5.1879-1881.2002 · Cited by 72
Differences in virulence of clinical isolates of Candida tropicalis and Candida albicans in mice
Wingard, J. R., Dick, J. D., Merz, W. G., Sandford, G. R., Saral, R., & Burns, W. H. (1982) · Infection and Immunity · doi:10.1128/iai.37.2.833-836.1982 · Cited by 72
Ketoconazole Prevents Candida Sepsis in Critically Ill Surgical Patients
Slotman, G. J. (1987) · Archives of Surgery · doi:10.1001/archsurg.1987.01400140029002 · Cited by 71
Siwek, G., Pfaller, M. A., Polgreen, P. M., Cobb, S., Hoth, P. L., Silverman, M. M., & Diekema, D. J. (2006) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2006.01.018 · Cited by 70
Candida Species: Emerging Hospital Bloodstream Pathogens
Wenzel, R. P., & Pfaller, M. A. (1991) · Infection Control and Hospital Epidemiology · doi:10.1086/646403 · Cited by 68
Savino, J. A., Agarwal, N., Wry, P., Policastro, A., Cerabona, T., & Austria, L. (1994) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/00005373-199401000-00004 · Cited by 68
Candida glabrata Endophthalmitis Treated Successfully with Caspofungin
Sarria, J. C., Bradley, J. C., Habash, R., Mitchell, K. T., Kimbrough, R. C., & Vidal, A. M. (2005) · Clinical Infectious Diseases · doi:10.1086/427753 · Cited by 68
Resistance to amphotericin B: emerging clinical and microbiological patterns
Sterling, T. R., & Merz, W. G. (1998) · Drug Resistance Updates · doi:10.1016/s1368-7646(98)80034-4 · Cited by 66
Candida in Burns: Risk Factors and Outcomes
Moore, E. C., Padiglione, A. A., Wasiak, J., Paul, E. M., & Cleland, H. J. (2010) · Journal of Burn Care & Research · doi:10.1097/bcr.0b013e3181d0f536 · Cited by 65
Excess Costs of Hospital Care Associated With Neonatal Candidemia
Smith, P. B., Morgan, J., Benjamin, D. K., Fridkin, S. K., Sanza, L. T., Harrison, L. H., Sofair, A. N., Huie-White, S., & Benjamin, D. K. (2007) · Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000253973.89097.c0 · Cited by 65
Playford, E. G., Lipman, J., Kabir, M., McBryde, E. S., Nimmo, G. R., Lau, A. F., & Sorrell, T. C. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1619-9 · Cited by 64
Presterl, E., Daxböck, F., Graninger, W. B., & Willinger, B. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01812.x · Cited by 63
St-Germain, G., Laverdière, M., Pelletier, R., René, P., Bourgault, A.-M., Lemieux, C., & Libman, M. (2008) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2008/634046 · Cited by 60
Nakamura, T., & Takahashi, H. (2006) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-006-0438-y · Cited by 56
Krčméry, V., & Kovacicova, G. (2000) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(99)00096-6 · Cited by 56
Effectiveness of Anidulafungin in Eradicating Candida Species in Invasive Candidiasis
Pfaller, M. A., Diekema, D. J., Boyken, L., Messer, S. A., Tendolkar, S., Hollis, R. J., & Goldstein, B. P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4795-4797.2005 · Cited by 56
Al-Tawfiq, J. A. (2007) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2006.03.003 · Cited by 54
Janssen, P. A., & van den Bossche, H. (1982) · PubMed · Cited by 54
Candidemia: The Impact of Antifungal Prophylaxis in a Surgical Intensive Care Unit
Swoboda, S. M., Merz, W. G., & Lipsetta, P. A. (2003) · Surgical Infections · doi:10.1089/109629603322761409 · Cited by 54
Pfaller, M. A., Boyken, L., Messer, S. A., Tendolkar, S., Hollis, R. J., & Diekema, D. J. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.11.4977-4979.2004 · Cited by 50
Dannaoui, É., Paugam, A., Develoux, M., Chochillon, C., Matheron, J., Datry, A., Bouges‐Michel, C., Bonnal, C., Dromer, F., & Bretagne, S. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02997.x · Cited by 49
Prophylaxis and treatment of invasive candidiasis in the intensive care setting
Ostrosky-Zeichner, L. L. (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1215-4 · Cited by 48
Vardakas, K. Z., Michalopoulos, A. S., Kiriakidou, K. G., Siampli, E. P., Samonis, G., & Falagas, M. E. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02653.x · Cited by 47
A prospective epidemiological survey of candidaemia in Sweden
Klingspor, L., Törnqvist, E., Johansson, A., Petrini, B., Forsum, U., & Hedin, G. (2004) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540310017447 · Cited by 46
Candida infections: outcome and attributable ICU costs in critically ill patients
Pelz, R. K., Lipsett, P. A., Swoboda, S. M., Diener-West, M., Powe, N. R., Brower, R. G., Perl, T. M., Hammond, J. M., & Hendrix, C. W. (2000) · Journal of Intensive Care Medicine · doi:10.1046/j.1525-1489.2000.00255.x · Cited by 45
Impact of Nosocomial Infections on Outcome: Myths and Evidence
Rello, J. (1999) · Infection Control & Hospital Epidemiology · doi:10.1086/501638 · Cited by 44
Mahieu, L. M., Van Gasse, N., Wildemeersch, D., Jansens, H., & Ieven, M. (2010) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0b013e3181b808fb · Cited by 43
Lockhart, S. R., Messer, S. A., Pfaller, M. A., & Diekema, D. J. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01889-08 · Cited by 41
Intravenous catheter-associated fungemia due to Candida rugosa
Reinhardt, J. F., Ruane, P. J., Walker, L. J., & George, W. L. (1985) · Journal of Clinical Microbiology · doi:10.1128/jcm.22.6.1056-1057.1985 · Cited by 41
A one-year survey of candidemia in Belgium in 2002
SWINNE, D., WATELLE, M., SUETENS, C., MERTENS, K., FONTEYNE, P.-A., & NOLARD, N. (2004) · Epidemiology and Infection · doi:10.1017/s095026880400295x · Cited by 39
Antifungal Susceptibility Testing Methods
Pfaller, M. (2005) · Current Drug Targets · doi:10.2174/138945005774912708 · Cited by 38
Anidulafungin: an echinocandin antifungal
Pfaller, M. A. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.9.1183 · Cited by 38
Magill, S. S., Swoboda, S. M., Shields, C. E., Colantuoni, E. A., Fothergill, A. W., Merz, W. G., Lipsett, P. A., & Hendrix, C. W. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e31819ed914 · Cited by 38
Problems and Controversies in the Management of Hematogenous Candidiasis
Uzun, O., & Anaissie, E. J. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.supplement_2.s95 · Cited by 38
Candida glabrata sepsis secondary to oral colonization in bone marrow transplantation
Redding, S. W., Marr, K. A., Kirkpatrick, W. R., Coco, B. J., & Patterson, T. F. (2004) · Medical Mycology · doi:10.1080/13693780410001731574 · Cited by 38
Epidemiology of Candidemia in a Turkish tertiary care hospital
BAKIR, M., CERIKCIOGLU, N., BARTON, R., & YAGCI, A. (2006) · APMIS · doi:10.1111/j.1600-0463.2006.apm_359.x · Cited by 37
Candidaemia in an Irish tertiary referral hospital: epidemiology and prognostic factors
Boo, T. W., O'Reilly, B., O'Leary, J., & Cryan, B. (2005) · Mycoses · doi:10.1111/j.1439-0507.2005.01134.x · Cited by 37
Dizbay, M., Fidan, I., Kalkanci, A., Sari, N., Yalcin, B., Kustimur, S., & Arman, D. (2010) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365540903321572 · Cited by 35
Nho, S. W., Anderson, M. J., Moore, C. B., & Denning, D. W. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.4.1036-1039.1997 · Cited by 35
Meningococcal disease in Dallas County, Texas: results of a six-year population-based study
PASTOR, P., MEDLEY, F. B., & Murphy, T. V. (2000) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200004000-00012 · Cited by 34
The Meningococcal Vaccine — Public Policy and Individual Choices
Offit, P. A., & Peter, G. (2003) · New England Journal of Medicine · doi:10.1056/nejmsb035678 · Cited by 33
Research works printed but not linked: 3
- Hsin-Yun, 2010, Int J Antimicrob Agents, 353, 211
- Pfaller, 2007, J Invasive Fungal Infect, 1, 74
- Oxman, 2010, hemother, 65, 1460
Cited by
Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision
Bongomin, F., Gago, S., Oladele, R., & Denning, D. (2017) · Journal of Fungi · doi:10.3390/jof3040057 · Cited by 2,953
“Comparisons of the incidence across countries is difficult as recent local epidemiological data was only available for 20 of the countries and the others used an incidence of 5 per 100,000 cases for their estimations [46].”
BackgroundKullberg, B. J., & Arendrup, M. C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1315399 · Cited by 1,315
Self-citationBranzk, N., Lubojemska, A., Hardison, S. E., Wang, Q., Gutierrez, M. G., Brown, G. D., & Papayannopoulos, V. (2014) · Nature Immunology · doi:10.1038/ni.2987 · Cited by 1,037
Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance
Krcmery, V., & Barnes, A. J. (2002) · Journal of Hospital Infection · doi:10.1053/jhin.2001.1151 · Cited by 733
Antifungal Resistance and New Strategies to Control Fungal Infections
Vandeputte, P., Ferrari, S., & Coste, A. T. (2012) · International Journal of Microbiology · doi:10.1155/2012/713687 · Cited by 505
Metadata
- Authors
- Arendrup, M. C.
- Affiliations
- Statens Serum Institut (DK)
- Corresponding author
- Arendrup, Maiken C
- ORCID
- Arendrup, Maiken C
- Venue
- Current Opinion in Critical Care
- Published
- 2010-10
- Volume
- 16
- Issue
- 5
- Pages
- 445-452
- ISSN
- 1070-5295 (ISSN-L)
- OpenAlex
- W2088977070
- Cited by
- 376
- References
- 212
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 12 · 2023: 15 · 2022: 14 · 2021: 24 · 2020: 30 · 2019: 25 · 2018: 35 · 2017: 27 · 2016: 24 · 2015: 33 · 2014: 27 · 2013: 35 · 2012: 32
- FWCI
- 3.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Critical Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- Astellas Pharma
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Keywords
- invasive candidiasis, candidemia, Candida parapsilosis, Candida glabrata, Candida krusei, Candida guilliermondii, antifungal susceptibility, azole resistance, echinocandin resistance, fluconazole, risk factors, mortality, intensive care unit, abdominal surgery, antifungal therapy
- MeSH terms
- Disease Susceptibility, Humans, Intensive Care Units, Species Specificity, Candidiasis, Invasive, Candidemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.